1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Elephantiasis (Lymphatic Filariasis) Global Clinical Trials Review, H2, 2015

Elephantiasis (Lymphatic Filariasis) Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Elephantiasis (Lymphatic Filariasis) Global Clinical Trials Review, H2, 2015" provides an overview of Elephantiasis (Lymphatic Filariasis) clinical trials scenario. This report provides top line data relating to the clinical trials on Elephantiasis (Lymphatic Filariasis). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Elephantiasis (Lymphatic Filariasis) Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Elephantiasis (Lymphatic Filariasis) to Infectious Disease Clinical Trials 14
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Elephantiasis (Lymphatic Filariasis) to Infectious Disease Clinical Trials 18
Clinical Trials by Phase in E7 Countries 20
Clinical Trials in E7 Countries by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Clinical Trials by End Point Status 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Elephantiasis (Lymphatic Filariasis) Therapeutics Clinical Trials 29
Prominent Drugs 30
Clinical Trial Profile Snapshots 31
Appendix 43
Abbreviations 43
Definitions 43
Research Methodology 44
Secondary Research 44
About GlobalData 45
Contact Us 45
Disclaimer 45
Source 46

List of Tables
Elephantiasis (Lymphatic Filariasis) Therapeutics, Global, Clinical Trials by Region, 2015* 6
Elephantiasis (Lymphatic Filariasis) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Elephantiasis (Lymphatic Filariasis) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Elephantiasis (Lymphatic Filariasis) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Elephantiasis (Lymphatic Filariasis) Therapeutics Clinical Trials, Europe, Top Countries, 2015* 11
Elephantiasis (Lymphatic Filariasis) Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Elephantiasis (Lymphatic Filariasis) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13
Proportion of Elephantiasis (Lymphatic Filariasis) to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 15
Elephantiasis (Lymphatic Filariasis) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Elephantiasis (Lymphatic Filariasis) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Elephantiasis (Lymphatic Filariasis) to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 19
Elephantiasis (Lymphatic Filariasis) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 20
Elephantiasis (Lymphatic Filariasis) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 21
Elephantiasis (Lymphatic Filariasis) Therapeutics, Global, Clinical Trials by Phase, 2015* 22
Elephantiasis (Lymphatic Filariasis) Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 23
Elephantiasis (Lymphatic Filariasis) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 24
Elephantiasis (Lymphatic Filariasis) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 25
Elephantiasis (Lymphatic Filariasis) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26
Elephantiasis (Lymphatic Filariasis) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 27
Elephantiasis (Lymphatic Filariasis) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
Elephantiasis (Lymphatic Filariasis) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Elephantiasis (Lymphatic Filariasis) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30

List of Figures
Elephantiasis (Lymphatic Filariasis) Therapeutics, Global, Clinical Trials by Region (%), 2015* 6
Elephantiasis (Lymphatic Filariasis) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Elephantiasis (Lymphatic Filariasis) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Elephantiasis (Lymphatic Filariasis) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10
Elephantiasis (Lymphatic Filariasis) Therapeutics Clinical Trials, Europe, Top Countries (%), 2015* 11
Elephantiasis (Lymphatic Filariasis) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13
Proportion of Elephantiasis (Lymphatic Filariasis) to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 14
Elephantiasis (Lymphatic Filariasis) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Elephantiasis (Lymphatic Filariasis) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Elephantiasis (Lymphatic Filariasis) to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 18
Elephantiasis (Lymphatic Filariasis) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 20
Elephantiasis (Lymphatic Filariasis) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 21
Elephantiasis (Lymphatic Filariasis) Therapeutics, Global, Clinical Trials by Phase (%), 2015* 22
Elephantiasis (Lymphatic Filariasis) Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 23
Elephantiasis (Lymphatic Filariasis) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 24
Elephantiasis (Lymphatic Filariasis) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 25
Elephantiasis (Lymphatic Filariasis) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26
Elephantiasis (Lymphatic Filariasis) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 27
Elephantiasis (Lymphatic Filariasis) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
Elephantiasis (Lymphatic Filariasis) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Elephantiasis (Lymphatic Filariasis) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30
GlobalData Methodology 44

Companies Mentioned
Johnson and Johnson
International Trachoma Initiative

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.